In section Releases

Leprino Nutrition Targets Protein Formulation Gaps at IFT FIRST 2026

As consumer appetite for high-protein foods intensifies, manufacturers are struggling to balance label claims with sensory quality. Leprino Nutrition intends to address these technical hurdles at the upcoming IFT FIRST 2026 conference in Chicago, showcasing specialty dairy ingredients designed to resolve common issues like chalkiness and flavor instability.

Leprino Nutrition Targets Protein Formulation Gaps at IFT FIRST 2026

The shift toward high-performance protein has exposed a divide between simple fortification and product viability. Brands attempting to boost protein levels often encounter unwanted viscosity, texture degradation, and scale-up failures. Angela Queneau, senior director of research and development at Leprino Nutrition, argues that true performance requires ingredients engineered specifically to function within complex, modern food systems.

At booth S2336 in McCormick Place, the company will spotlight three specific solutions: Micellar Casein Isolate, which provides heat stability and neutral flavor; MP PRO C80, a microparticulated whey concentrate aimed at improving mouthfeel; and CLEAR PRO 90, a whey isolate designed for low-viscosity, stable beverages. These products aim to replace commodity proteins that frequently fail when pushed into advanced applications.

Beyond the ingredient portfolio, the firm is positioning its Application & Customer Experience team as a strategic partner. Vice president of sales and marketing B.T. Nauslar noted that the company treats client formulations with the same rigor as in-house R&D teams. By leveraging 75 years of dairy infrastructure, Leprino aims to provide the supply chain reliability and technical troubleshooting necessary to move products from conceptualization to global commercialization.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!